Bayer Aktiengesellschaft (BAYZF)

Market Cap	25.37B
Revenue (ttm)	48.25B
Net Income (ttm)	-2.64B
Shares Out	n/a
EPS (ttm)	-2.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Average Volume	3,223
Open	25.70
Previous Close	25.31
Day's Range	25.49 - 25.70
52-Week Range	19.50 - 34.01
Beta	1.05
RSI	66.63
Earnings Date	Mar 5, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare produc...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1863
• Employees: 96,931
• Stock Exchange: OTCMKTS
• Ticker Symbol: BAYZF

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR